Treatment-related toxicities
. | No. of patients (%), grades 1 and 2 . | No. of patients (%), grades 3 and 4 . |
---|---|---|
Nonhematologic | ||
Fatigue | 6 (46) | 4 (31) |
Somnolence | 4 (31) | 0 (0) |
Constipation | 8 (61) | 0 (0) |
Neuropathy | 8 (61) | 0 (0) |
Pulmonary thromboembolism | 0 (0) | 2 (15) |
Rash | 4 (31) | 0 (0) |
Flare reaction* | 6 (46) | 0 (0) |
Pedal edema | 0 (0) | 1 (8) |
Diarrhea | 0 (0) | 1 (8) |
Hematologic | ||
Anemia | 5 (38) | 0 (0) |
Leukopenia | 0 (0) | 1 (8) |
Neutropenia | 3 (23) | 1 (8) |
Thrombocytopenia | 7 (54) | 0 (0) |
. | No. of patients (%), grades 1 and 2 . | No. of patients (%), grades 3 and 4 . |
---|---|---|
Nonhematologic | ||
Fatigue | 6 (46) | 4 (31) |
Somnolence | 4 (31) | 0 (0) |
Constipation | 8 (61) | 0 (0) |
Neuropathy | 8 (61) | 0 (0) |
Pulmonary thromboembolism | 0 (0) | 2 (15) |
Rash | 4 (31) | 0 (0) |
Flare reaction* | 6 (46) | 0 (0) |
Pedal edema | 0 (0) | 1 (8) |
Diarrhea | 0 (0) | 1 (8) |
Hematologic | ||
Anemia | 5 (38) | 0 (0) |
Leukopenia | 0 (0) | 1 (8) |
Neutropenia | 3 (23) | 1 (8) |
Thrombocytopenia | 7 (54) | 0 (0) |
Tenderness and increased swelling of the involved lymph nodes